MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1

Inhibitors of MET have not produced satisfactory outcomes in trials of patients with liver cancer. We investigated the mechanisms of liver tumor resistance to MET inhibitors in mice. We tested the effects of MET inhibitors tivantinib and capmatinib in the mouse hepatocellular carcinoma (HCC) cell li...

Full description

Saved in:
Bibliographic Details
Published in:Gastroenterology (New York, N.Y. 1943) Vol. 156; no. 6; p. 1849
Main Authors: Li, Hui, Li, Chia-Wei, Li, Xiaoqiang, Ding, Qingqing, Guo, Lei, Liu, Shuang, Liu, Chunxiao, Lai, Chien-Chen, Hsu, Jung-Mao, Dong, Qiongzhu, Xia, Weiya, Hsu, Jennifer L, Yamaguchi, Hirohito, Du, Yi, Lai, Yun-Ju, Sun, Xian, Koller, Paul B, Ye, Qinghai, Hung, Mien-Chie
Format: Journal Article
Language:English
Published: United States 01.05.2019
Subjects:
ISSN:1528-0012, 1528-0012
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first